Literature DB >> 7774000

Hepatocellular carcinoma: efficacy of transcatheter oily chemoembolization in relation to macroscopic and microscopic patterns of tumor growth among 100 patients with partial hepatectomy.

T Hashimoto1, H Nakamura, S Hori, K Tomoda, K Nakanishi, T Murakami, T Kozuka, M Monden, M Gotoh, C Kuroda.   

Abstract

PURPOSE: To evaluate the efficacy of transcatheter oily chemoembolization (TOCE) for hepatocellular carcinoma (HCC) on the basis of microscopic and macroscopic findings postembolization.
METHODS: HCCs ranging in size from 0.5 to 13 cm (mean 3.6 cm) were obtained from partial hepatectomies of 100 consecutive patients who had undergone TOCE between 20 and 246 days (mean 59.5 days) prior to surgery. The efficacy of TOCE was assessed on the basis of the necrotic to live cell ratio of the tumors. The microscopic pattern of tumor growth was grouped into expanding type (complete capsule formation) and replacing type (incomplete or no capsule). There were five types of macroscopic groupings: single nodule, single nodule with extranodular growth (SNE), contiguous and noncontiguous multinodular, and massive growth type.
RESULTS: Among 79 cases with the expanding type, 29 (37%) had 100% HCC necrosis, but none with 100% necrosis were in the replacing type. By macroscopic grouping, the efficacy of TOCE decreased from the single nodule type (50% of patients had 100% necrosis) to the SNE type (21%), and the other types (9%).
CONCLUSION: TOCE appears to be most efficacious for HCC with the expanding growth pattern and HCC forming single nodules. Poor results are to be expected in HCC of replacing growth type and multinodular or massive growth types.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7774000     DOI: 10.1007/bf02807227

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  13 in total

1.  Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies.

Authors:  H A EDMONDSON; P E STEINER
Journal:  Cancer       Date:  1954-05       Impact factor: 6.860

2.  Clinicopathologic features of encapsulated hepatocellular carcinoma: a study of 26 cases.

Authors:  K Okuda; H Musha; Y Nakajima; Y Kubo; Y Shimokawa; Y Nagasaki; Y Sawa; S Jinnouchi; T Kaneko; H Obata; T Hisamitsu; Y Motoike; N Okazaki; M Kojiro; K Sakamoto; T Nakashima
Journal:  Cancer       Date:  1977-09       Impact factor: 6.860

3.  A new approach to chemoembolization therapy for hepatoma using ethiodized oil, cisplatin, and gelatin sponge.

Authors:  Y Sasaki; S Imaoka; H Kasugai; M Fujita; S Kawamoto; S Ishiguro; J Kojima; O Ishikawa; H Ohigashi; H Furukawa
Journal:  Cancer       Date:  1987-09-15       Impact factor: 6.860

4.  Hepatic artery embolization in 120 patients with unresectable hepatoma.

Authors:  R Yamada; M Sato; M Kawabata; H Nakatsuka; K Nakamura; S Takashima
Journal:  Radiology       Date:  1983-08       Impact factor: 11.105

5.  Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents.

Authors:  K Takayasu; Y Shima; Y Muramatsu; N Moriyama; T Yamada; M Makuuchi; H Hasegawa; S Hirohashi
Journal:  Radiology       Date:  1987-05       Impact factor: 11.105

6.  Transcatheter oily chemoembolization of hepatocellular carcinoma.

Authors:  H Nakamura; T Hashimoto; H Oi; S Sawada
Journal:  Radiology       Date:  1989-03       Impact factor: 11.105

7.  Histologic growth pattern of hepatocellular carcinoma: relationship to orcein (hepatitis B surface antigen)-positive cells in cancer tissue.

Authors:  T Nakashima; M Kojiro; Y Kawano; F Shirai; N Takemoto; Y Tomimatsu; H Kawasaki; K Okuda
Journal:  Hum Pathol       Date:  1982-06       Impact factor: 3.466

8.  Ultrastructural study of hepatocellular carcinoma with replacing growth pattern.

Authors:  S Sugihara; M Kojiro; T Nakashima
Journal:  Acta Pathol Jpn       Date:  1985-05

9.  Transcatheter embolization of hepatocellular carcinoma: assessment of efficacy in cases of resection following embolization.

Authors:  H Nakamura; T Tanaka; S Hori; H Yoshioka; C Kuroda; J Okamura; M Sakurai
Journal:  Radiology       Date:  1983-05       Impact factor: 11.105

10.  Pathology of small hepatocellular carcinoma. A proposal for a new gross classification.

Authors:  T Kanai; S Hirohashi; M P Upton; M Noguchi; K Kishi; M Makuuchi; S Yamasaki; H Hasegawa; K Takayasu; N Moriyama
Journal:  Cancer       Date:  1987-08-15       Impact factor: 6.860

View more
  8 in total

Review 1.  Ethanol injection for the treatment of hepatic tumours.

Authors:  C Bartolozzi; R Lencioni
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

2.  A Changing Paradigm for the Treatment of Intermediate-Stage Hepatocellular Carcinoma: Asia-Pacific Primary Liver Cancer Expert Consensus Statements.

Authors:  Masatoshi Kudo; Kwang-Hyub Han; Sheng-Long Ye; Jian Zhou; Yi-Hsiang Huang; Shi-Ming Lin; Chung-Kwe Wang; Masafumi Ikeda; Stephen Lam Chan; Su Pin Choo; Shiro Miyayama; Ann Lii Cheng
Journal:  Liver Cancer       Date:  2020-05-13       Impact factor: 11.740

Review 3.  Sequential transarterial chemoembolization for unresectable advanced hepatocellular carcinoma.

Authors:  H J Jaeger; U M Mehring; F Castañeda; F Hasse; G Blumhardt; D Loehlein; K D Mathias
Journal:  Cardiovasc Intervent Radiol       Date:  1996 Nov-Dec       Impact factor: 2.740

4.  Mutation Detection of Fibroblast Growth Factor Receptor 3 for Infiltrative Hepatocellular Carcinoma by Whole-Exome Sequencing.

Authors:  Xiaopeng Yan; Cong Shao; Chuang Chen; Jun Chen; Shen Gu; Luoshun Huang; Xu Fu; Hui Zhao; Yudong Qiu
Journal:  Dig Dis Sci       Date:  2017-01-05       Impact factor: 3.199

5.  Chemoembolisation combined with percutaneous radiofrequency ablation in the treatment of primary angiosarcoma of the liver.

Authors:  Thiago Franchi Nunes; Fabio Colagrossi Paes Barbosa; Luciana Nakao Odashiro Miiji; Luiz Gustavo Orlandi de Souza
Journal:  BMJ Case Rep       Date:  2013-05-22

6.  Predictive factors of tumor response to trans-catheter treatment in cirrhotic patients with hepatocellular carcinoma: a multivariate analysis of pre-treatment findings.

Authors:  Roberto Miraglia; Giada Pietrosi; Luigi Maruzzelli; Ioannis Petridis; Settimo Caruso; Gianluca Marrone; Giuseppe Mamone; Giovanni Vizzini; Angelo Luca; Bruno Gridelli
Journal:  World J Gastroenterol       Date:  2007-12-07       Impact factor: 5.742

7.  Treatment with transcatheter arterial chemoembolization induces an increase of the L-selectin(low) CXCR3+ CD8+ T cell subset in patients with hepatocellular carcinoma.

Authors:  Jiasheng Zheng; Bin Sun; Daojie Liu; Li Yan; Yanjun Wang
Journal:  Onco Targets Ther       Date:  2012-06-08       Impact factor: 4.147

8.  Effect of ultrasound-guided radiofrequency ablation in incompletely treated hepatocellular carcinoma after transcatheter arterial chemoembolization.

Authors:  Nam Kyu Chang; Sang Soo Shin; Jin Woong Kim; Hyung Jun Kim; Yong Yeon Jeong; Suk Hee Heo; Jae Kyu Kim; Heoung Keun Kang
Journal:  Korean J Radiol       Date:  2012-04-23       Impact factor: 3.500

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.